Recruiting at 166 sites Phase 3 Alzheimers Disease

Clinical trial for Alzheimers Disease

Official title Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies

ClinicalTrials.gov ID: NCT07177352

What this study is testing

What it's testing
The study aims to identify individuals who could be eligible for future Roche interventional trials for Alzheimer's disease.
Who it's for
People who have Alzheimer's disease and are interested in joining a drug trial.
What's involved
Participants will undergo screening assessments, such as medical questionnaires and basic tests, to evaluate eligibility.
Time commitment
A single screening visit lasting a few hours.
  • Phase 3: a large, late-stage study

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 50 to 90

You may be able to join if

  • Ability and willingness to participate in an treatment clinical study, including meeting key eligibility criteria of linked treatment Roche AD...
  • Ability and willingness to receive information about potential eligibility in an associated treatment Roche AD study

You likely can't join if

  • Dependency in basic activities of daily living (bADLs) due to cognitive impairment
  • Visual or auditory impairment that would prevent them from performing the cognitive assessments (eyeglasses and hearing aids are permitted)
  • Any self-reported evidence or known diagnosis of a neurological or neurodegenerative condition that may lead to cognitive impairment other than AD
  • History of severe, clinically significant central nervous system trauma
  • Any serious medical condition that precludes a participant's safe participation and completion of a clinical study
  • For participants with a clinical diagnosis of MCI or mild AD: Previous AD diagnosis based on biomarker confirmation with an approved or validated...

The study team makes the final eligibility decision.

Where it is enrolling

  • Birmingham, Alabama, United States
  • Phoenix, Arizona, United States
  • Sun City, Arizona, United States
  • Imperial, California, United States
  • Irvine, California, United States
  • Long Beach, California, United States
  • Los Angeles, California, United States
  • Oakland, California, United States
  • Riverside, California, United States
  • Santa Ana, California, United States
  • Sherman Oaks, California, United States
  • New Haven, Connecticut, United States
  • Atlantis, Florida, United States
  • Clermont, Florida, United States
  • Lady Lake, Florida, United States
  • Maitland, Florida, United States
  • Miami, Florida, United States
  • Ocala, Florida, United States
  • Orlando, Florida, United States
  • Stuart, Florida, United States

+ 106 more site(s).

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 50 years to 90 years. The study team makes the final eligibility decision.

Where is this trial taking place?

This study is enrolling now at Birmingham, Alabama, United States; Phoenix, Arizona, United States; Sun City, Arizona, United States; Imperial, California, United States; Irvine, California, United States; Long Beach, California, United States and 120 more locations. Enter your location above to see the nearest enrolling site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.